Skip to content
AnalystLens

PROCTER & GAMBLE Co Annual Report, Year Ended Jun 30, 2019

Filing Date
Filed August 6, 2019
Period End
June 30, 2019
Security
PG
One revenue dollarkept$0.06
In the record · 2016–202610-K1210-Q328-K224

PG filed 12 annual reports (10-K), 32 quarterly reports (10-Q) and 224 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Apr ’22Apr ’22
  2. Leadership change8-K · Jul ’26Jul ’26

Summary

Summary of the 10-K filed August 6, 2019. Cited figures are marked; the original filing is the authoritative source.

Procter & Gamble's (PG) 2019 10-K filing highlights a challenging year primarily impacted by a significant $8.3 billiona goodwill and intangible asset impairment charge related to its Shave Care business.

This charge led to a substantial decrease in reported net earnings and diluted EPS. Despite this, the company demonstrated resilience with a 5% organic sales increase driven by a 2% rise in organic volume across its segments, with notable strength in Beauty and Fabric & Home Care. Operationally, P&G continued its focus on productivity improvements, evident in its strong Adjusted Free Cash Flow (AFF) of $12.1 billionb and robust AFF productivity of 105%.

The company also returned significant capital to shareholders through dividends, increasing the payout by 4%c for the 63rd consecutive year, and share repurchases. Strategic acquisitions, like the Merck KGaA OTC healthcare business, were completed, while organizational changes were implemented to drive future growth. Investors should note the company's ongoing efforts to streamline its portfolio and focus on core, high-performing brands.

Key Highlights

  1. Significant $8.3 billion goodwill and intangible asset impairment charge in the Shave Care segment negatively impacted reported net earnings and EPS.
  2. Organic sales grew 5% driven by a 2% increase in organic volume, with Beauty and Fabric & Home Care segments showing mid-to-high single-digit organic sales growth.
  3. Adjusted Free Cash Flow (AFF) was $12.1 billion, with AFF productivity at a strong 105%, indicating effective cash generation.
  4. The company continued its commitment to shareholder returns by increasing its dividend by 4% for the 63rd consecutive year and repurchasing $5 billion in shares.
  5. Acquired the Merck KGaA OTC healthcare business for $3.7 billion to strengthen its Health Care segment.
  6. Implemented organizational design changes effective July 1, 2019, reorganizing into six Sector Business Units (SBUs) to drive future growth.
  7. Walmart remains the largest customer, accounting for approximately 15% of total sales, with no other single customer exceeding 10%.

Follow one dollar

Of each $1.00 of revenue in FY2019, Procter & Gamble Co kept $0.06.

  1. Revenue$67.68B100.0%
  2. Cost of revenue−$34.77B51.4%
  3. Gross profit$32.92B48.6%
  4. Operating costs−$27.43B40.5%
  5. Operating income$5.49B8.1%
  6. Interest, other & tax−$1.59B2.3%
  7. Net income$3.90B5.8%
Computed from 10-KFY2019filed August 6, 2019Computed from this filing’s revenue, gross profit, operating income and net income · right columngrey figure: share of revenue

Where FY2019 revenue went

$67.68B
  • Cost of revenue: $34.77B, 51% of revenue
  • SG&A: $19.08B, 28% of revenue
  • Net income: $3.90B, 5.8% of revenue
  • R&D: $1.90B, 2.8% of revenue
  • Other operating costs: $6.45B, 9.5% of revenue
  • Interest, other & tax: $1.59B, 2.3% of revenue

Kept 5.8% as net incomeNet income $3.90B · 5.8%

Full revenue history →

Financial Statements

FY2019 against FY2018

Line itemFY2019FY2018Change
Revenue$67.68B$66.83B+1.3%
Cost of Revenue$34.77B$34.43B+1.0%
Gross Profit$32.92B$32.40B+1.6%
R&D Expenses$1.90B$1.90B0.0%
SG&A Expenses$19.08B$19.04B+0.2%
Operating Income$5.49B$13.36B−58.9%
Interest Expense$509.00M$506.00M+0.6%
Net Income$3.90B$9.75B−60.0%
EPS (Basic)$1.45$3.75−61.3%
EPS (Diluted)$1.43$3.67−61.0%
Shares Outstanding (Basic)2.50B2.53B−1.0%
Shares Outstanding (Diluted)2.54B2.66B−4.4%

Frequently Asked Questions

  1. What caused the significant decrease in reported net earnings for fiscal year 2019?

    The primary driver for the decrease in reported net earnings was an $8.3 billion non-cash impairment charge related to goodwill and indefinite-lived intangible assets in the Shave Care segment, specifically impacting the Gillette brand.

  2. How did the company's organic sales perform in fiscal year 2019?

    Procter & Gamble reported a 5% increase in organic sales, driven by a 2% increase in organic volume. Key segments like Beauty and Fabric & Home Care showed particularly strong performance with mid-to-high single-digit organic sales growth.

  3. What is the company's stance on returning capital to shareholders?

    P&G continues to prioritize shareholder returns. In fiscal year 2019, the company increased its dividend by 4% for the 63rd consecutive year and repurchased approximately $5 billion of its own stock, demonstrating a consistent commitment to capital allocation.

  4. Did the company make any significant acquisitions or divestitures during the year?

    Yes, P&G completed the acquisition of Merck KGaA's OTC healthcare business for $3.7 billion, aiming to bolster its Health Care segment. The company also dissolved its PGT Healthcare partnership.